The PSA-/lo prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration

Cell Stem Cell

Volumn 10, Issue 5, 2012, Pages 556-569

  Qin, Jichao ^a,b   Liu, Xin ^a,c   Laffin, Brian ^a   Chen, Xin ^a,d   Choy, Grace ^a   Jeter, Collene R ^a   Calhoun Davis, Tammy ^a   Li, Hangwen ^a,c   Palapattu, Ganesh S ^e   Pang, Shen ^f   Lin, Kevin ^a   Huang, Jiaoti ^g   Ivanov, Ivan ^h   Li, Wei ⁱ   Suraneni, Mahipal V ^a   Tang, Dean G ^a,d,j,k  

^a UNIVERSITY OF TEXAS   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f UCLA SCHOOL OF DENTISTRY   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h TEXAS A AND M UNIVERSITY   (United States)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k TONGJI UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASYMMETRIC CELL DIVISION; CANCER CELL; CANCER INVASION; CARCINOGENESIS; CASTRATION RESISTANT PROSTATE CANCER; CELL DIFFERENTIATION; CELL DIVISION; CELL RENEWAL; CLONOGENESIS; DISEASE MARKER; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER CELL; STEM CELL;

ADENOCARCINOMA; ANIMALS; ANTIGENS, DIFFERENTIATION; ASYMMETRIC CELL DIVISION; CASTRATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 84860642507     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2012.03.009     Document Type: Article

References (41)

1. P.A. Abrahamsson, H. Lilja, S. Falkmer, and L.B. Wadström Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands Prostate 12 1988 39 46
2. B. Bhatia, M. Jiang, M. Suraneni, L. Patrawala, M. Badeaux, R. Schneider-Broussard, A.S. Multani, C.R. Jeter, T. Calhoun-Davis, and L. Hu Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells J. Biol. Chem. 283 2008 27957 27972
3. J.M. Chan, M.J. Stampfer, E. Giovannucci, P.H. Gann, J. Ma, P. Wilkinson, C.H. Hennekens, and M. Pollak Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 1998 563 566
4. A.T. Collins, P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland Prospective identification of tumorigenic prostate cancer stem cells Cancer Res. 65 2005 10946 10951
5. J.N. Davis, K.J. Wojno, S. Daignault, M.D. Hofer, R. Kuefer, M.A. Rubin, and M.L. Day Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer Cancer Res. 66 2006 11897 11906
6. H.D. Feiner, and R. Gonzalez Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates Am. J. Surg. Pathol. 10 1986 765 770
7. M.P. Gallee, E. Visser-de Jong, J.A. van der Korput, T.H. van der Kwast, F.J. ten Kate, F.H. Schroeder, and J. Trapman Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens Urol. Res. 18 1990 181 187
8. A. Hobisch, Z. Culig, C. Radmayr, G. Bartsch, H. Klocker, and A. Hittmair Distant metastases from prostatic carcinoma express androgen receptor protein Cancer Res. 55 1995 3068 3072
9. J.T. Hsieh, H.C. Wu, M.E. Gleave, A.C. von Eschenbach, and L.W.K. Chung Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline Cancer Res. 53 1993 2852 2857
10. W.J. Huss, D.R. Gray, N.M. Greenberg, J.L. Mohler, and G.J. Smith Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells Cancer Res. 65 2005 6640 6650
11. C.R. Jeter, M. Badeaux, G. Choy, D. Chandra, L. Patrawala, C. Liu, T. Calhoun-Davis, H. Zaehres, G.Q. Daley, and D.G. Tang Functional evidence that the self-renewal gene NANOG regulates human tumor development Stem Cells 27 2009 993 1005
12. C.R. Jeter, B. Liu, X. Liu, X. Chen, C. Liu, T. Calhoun-Davis, J. Repass, H. Zaehres, J.J. Shen, and D.G. Tang NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation Oncogene 30 2011 3833 3845
13. T. Jiang, B.J. Collins, N. Jin, D.N. Watkins, M.V. Brock, W. Matsui, B.D. Nelkin, and D.W. Ball Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer Cancer Res. 69 2009 845 854
14. K.A. Klein, R.E. Reiter, J. Redula, H. Moradi, X.L. Zhu, A.R. Brothman, D.J. Lamb, M. Marcelli, A. Belldegrun, O.N. Witte, and C.L. Sawyers Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice Nat. Med. 3 1997 402 408
15. J.A. Knoblich Mechanisms of asymmetric stem cell division Cell 132 2008 583 597
16. B. Laffin, and D.G. Tang An old player on a new playground: bmi-1 as a regulator of prostate stem cells Cell Stem Cell 7 2010 639 640
17. H. Li, X. Chen, T. Calhoun-Davis, K. Claypool, and D.G. Tang PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells Cancer Res. 68 2008 1820 1825
18. C. Liu, K. Kelnar, B. Liu, X. Chen, T. Calhoun-Davis, H. Li, L. Patrawala, H. Yan, C. Jeter, and S. Honorio The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 Nat. Med. 17 2011 211 215
19. N.J. Maitland, F.M. Frame, E.S. Polson, J.L. Lewis, and A.T. Collins Prostate cancer stem cells: do they have a basal or luminal phenotype? Horm Cancer 2 2011 47 61
20. S. Memarzadeh, H. Cai, D.M. Janzen, L. Xin, R. Lukacs, M. Riedinger, Y. Zong, K. DeGendt, G. Verhoeven, J. Huang, and O.N. Witte Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal Proc. Natl. Acad. Sci. USA 108 2011 7962 7967
21. E.A. Mostaghel, S.T. Page, D.W. Lin, L. Fazli, I.M. Coleman, L.D. True, B. Knudsen, D.L. Hess, C.C. Nelson, and A.M. Matsumoto Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer Cancer Res. 67 2007 5033 5041
22. Y. Niu, S. Altuwaijri, K.P. Lai, C.T. Wu, W.A. Ricke, E.M. Messing, J. Yao, S. Yeh, and C. Chang Androgen receptor is a tumor suppressor and proliferator in prostate cancer Proc. Natl. Acad. Sci. USA 105 2008 12182 12187
23. - cancer cells are similarly tumorigenic Cancer Res. 65 2005 6207 6219
24. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 2006 1696 1708
25. + cell population is enriched in tumor-initiating cells Cancer Res. 67 2007 6796 6805
26. S. Pece, D. Tosoni, S. Confalonieri, G. Mazzarol, M. Vecchi, S. Ronzoni, L. Bernard, G. Viale, P.G. Pelicci, and P.P. Di Fiore Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content Cell 140 2010 62 73
27. V.K. Rajasekhar, L. Studer, W. Gerald, N.D. Socci, and H.I. Scher Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling Nat Commun 2 2011 162
28. M.P. Roudier, L.D. True, C.S. Higano, H. Vesselle, W. Ellis, P. Lange, and R.L. Vessella Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone Hum. Pathol. 34 2003 646 653
29. J.A. Ruizeveld de Winter, P.J. Janssen, H.M. Sleddens, M.C. Verleun-Mooijman, J. Trapman, A.O. Brinkmann, A.B. Santerse, F.H. Schröder, and T.H. van der Kwast Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer Am. J. Pathol. 144 1994 735 746
30. C.J. Ryan, A. Smith, P. Lal, J. Satagopan, V. Reuter, P. Scardino, W. Gerald, and H.I. Scher Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression Urology 68 2006 834 839
31. R.B. Shah, R. Mehra, A.M. Chinnaiyan, R. Shen, D. Ghosh, M. Zhou, G.R. Macvicar, S. Varambally, J. Harwood, and T.A. Bismar Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program Cancer Res. 64 2004 9209 9216
32. M.M. Shen, and C. Abate-Shen Molecular genetics of prostate cancer: new prospects for old challenges Genes Dev. 24 2010 1967 2000
33. D.G. Tang Understanding cancer stem cell heterogeneity and plasticity Cell Res. 22 2012 457 472
34. S.A. Tomlins, R. Mehra, D.R. Rhodes, X. Cao, L. Wang, S.M. Dhanasekaran, S. Kalyana-Sundaram, J.T. Wei, M.A. Rubin, and K.J. Pienta Integrative molecular concept modeling of prostate cancer progression Nat. Genet. 39 2007 41 51
35. C. van den Hoogen, G. van der Horst, H. Cheung, J.T. Buijs, J.M. Lippitt, N. Guzmán-Ramírez, F.C. Hamdy, C.L. Eaton, G.N. Thalmann, and M.G. Cecchini High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer Cancer Res. 70 2010 5163 5173
36. S. Varambally, J. Yu, B. Laxman, D.R. Rhodes, R. Mehra, S.A. Tomlins, R.B. Shah, U. Chandran, F.A. Monzon, and M.J. Becich Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression Cancer Cell 8 2005 393 406
37. Q. Wang, W. Li, Y. Zhang, X. Yuan, K. Xu, J. Yu, Z. Chen, R. Beroukhim, H. Wang, and M. Lupien Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Cell 138 2009 245 256
38. X. Wang, M. Kruithof-de Julio, K.D. Economides, D. Walker, H. Yu, M.V. Halili, Y.P. Hu, S.M. Price, C. Abate-Shen, and M.M. Shen A luminal epithelial stem cell that is a cell of origin for prostate cancer Nature 461 2009 495 500
39. M. Wu, H.Y. Kwon, F. Rattis, J. Blum, C. Zhao, R. Ashkenazi, T.L. Jackson, N. Gaiano, T. Oliver, and T. Reya Imaging hematopoietic precursor division in real time Cell Stem Cell 1 2007 541 554
40. T. Yoshida, H. Kinoshita, T. Segawa, E. Nakamura, T. Inoue, Y. Shimizu, T. Kamoto, and O. Ogawa Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient Cancer Res. 65 2005 9611 9616
41. D. Yu, D. Chen, C. Chiu, B. Razmazma, Y.H. Chow, and S. Pang Prostate-specific targeting using PSA promoter-based lentiviral vectors Cancer Gene Ther. 8 2001 628 635